Psy Therapeutics, Inc., a pioneering preclinical biopharmaceutical company, is thrilled to announce its successful funding round, having raised an impressive $12,590,000. This influx of capital will significantly bolster the company's ongoing mission to develop innovative treatments within the central nervous system (CNS) space, particularly targeting prevalent mental health conditions such as anxiety disorders, depression, and dementia. With a visionary approach, Psy Therapeutics has established a robust and promising pipeline of CNS therapeutics, fueled by a highly experienced team of neuroscientists, clinicians, and business leaders who are dedicated to advancing the future of mental health care. This funding will be utilized to propel the company's research programs forward, allowing for accelerated clinical trials and the expansion of their technological capabilities. The strategic collaborations and cutting-edge technologies that Psy employs will enable the firm to unlock new therapeutic avenues, ultimately creating substantial value for patients and stakeholders alike. As the world increasingly recognizes the importance of mental health treatment, Psy Therapeutics stands at the forefront of innovation, committed to not only improving the lives of individuals battling these challenging conditions but also reshaping the landscape of CNS care. This funding marks a pivotal moment in our journey, and we are excited about the advancements that lie ahead as we continue to pave the way toward better mental health solutions.
Psy Therapeutics Secures $12.59M in Funding for Revolutionary CNS Treatments
Get the full Psy Therapeutics company profile
Access contacts, investors, buying signals & more
Other recently funded companies
View all
Amani Therapeutics
Removing barriers with innovative science to deliver effective treatments for people living with serious psychiatric illness, restoring hope and stability to enable fuller lives.
$25.0M Series a
today
Neion Bio
At Neion Bio, we use breakthroughs in genetic engineering and stem cell biology to reinvent the entire manufacturing process for biopharmaceuticals. Our platform manufactures virtually any complex molecule with orders of magnitude superior cost, scalability, and resiliency. Biomanufacturing reinvented. Medicine, democratized.
$11.0M Seed
today
Massimo Motor Sports
Massimo pride and joy is our 325,000 square foot factory in the heart of the Dallas / Fort Worth area of Texas USA, in the city of Garland. It’s here we offer some of the most sought after, value packed UTV’s, off-road, and on-road vehicles in the industry. Our vast product lines include a wide selection of farm and ranch tested utility UTV’s, recreational ATV's, and Americana style mini-bikes. We work hard to continue to deliver one of the most diverse, value packed and expansive product-lines in the industry.
$4.0M Unknown
today
Harri
Harri is the frontline workforce operating system built by hospitality, for hospitality. We believe a great guest experience is only possible when employees are set up for success - which is why we've built the industry's most complete platform for attracting, managing, engaging and retaining top frontline talent. The Harri suite connects talent acquisition, workforce management, employee engagement and agentic AI in one place - giving operators everything they need to run their workforce intelligently, without the patchwork of point solutions. From autonomous AI scheduling and real-time labour intelligence to automated recognition and retention tools, Harri is built for the way hospitality actually operates.
$3.0M Unknown
today
Plastic Labs
Solving personal identity for the agentic world.
$13.3M Unknown
today